Filtered By:
Source: MMWR Morb Mortal Wkl...
Drug: Medroxyprogesterone
This page shows you your search results in order of date.
Order by Relevance | Date
Total 6 results found since Jan 2013.
Update to U.S. Selected Practice Recommendations for Contraceptive Use: Self-Administration of Subcutaneous Depot Medroxyprogesterone Acetate
MMWR Morb Mortal Wkly Rep. 2021 May 21;70(20):739-743. doi: 10.15585/mmwr.mm7020a2.ABSTRACTU.S. Selected Practice Recommendations for Contraceptive Use (U.S. SPR), adapted by CDC from global guidance developed by the World Health Organization (WHO), provides evidence-based guidance on contraceptive use for U.S. health care providers (1). During January-February, 2021, CDC evaluated the 2019 WHO recommendation on self-administered subcutaneous depot medroxyprogesterone acetate (DMPA-SC) (2). CDC adopted the WHO recommendation on the basis of moderate-certainty evidence that self-administered DMPA-SC is safe and effective, a...
Source: MMWR Morb Mortal Wkl... - May 20, 2021 Category: Epidemiology Authors: Kathryn M Curtis Antoinette Nguyen Jennifer A Reeves Elizabeth A Clark Suzanne G Folger Maura K Whiteman Source Type: research
